Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Frankel

Showing results (141-150 of 259) with videos related to

Pageof 26
Sort By:
Cancer Research|September 1, 1982
Monoclonal antibodies to a human prostate antigenA E Frankel, R V Rouse, M C Wang, et al.
Breast Cancer Research and Treatment|July 13, 2007
1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes inhibit proliferation of estrogen receptor-negative breast cancer cells by activation of multiple pathwaysKathy Vanderlaag, Yunpeng Su, Arthur E Frankel, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1989
An immunotoxin for the treatment of T-acute lymphoblastic leukemic meningitis: studies in rhesus monkeysA A Hertler, D M Schlossman, M J Borowitz, et al.
International Journal of Immunopharmacology|December 1, 1996
Ricin toxin contains three lectin sites which contribute to its in vivo toxicityT Fu, C Burbage, E P Tagge, et al.
Current Pharmaceutical Design|October 14, 2003
Novel protein targeted therapy of metastatic melanomaArthur E Frankel, Han-Mo Koo, Stephen H Leppla, et al.
Anti-Cancer Agents in Medicinal Chemistry|October 26, 2011
TEM8 targeted cancer therapyArthur E Frankel, Carol Carter, Shu-Ru Kuo, et al.
Clinical Immunology (Orlando, Fla.)|July 24, 2001
Antibody response to DT-GM, a novel fusion toxin consisting of a truncated diphtheria toxin (DT) linked to human granulocyte-macrophage colony stimulating factor (GM), during a phase I trial of patients with relapsed or refractory acute myeloid leukemiaP D Hall, G Virella, T Willoughby, et al.
Cancer Treatment and Research|January 1, 1988
Treatment of leukemia patients with T101 ricin A chain immunotoxinsG Laurent, A E Frankel, A A Hertler, et al.
Carbohydrate Research|May 16, 1997
Lectin-deficient ricin toxin intoxicates cells bearing the D-mannose receptorA E Frankel, T Fu, C Burbage, et al.
Journal of Neuro-Oncology|January 9, 2015
Human recombinant arginase I (Co)-PEG5000 [HuArgI (Co)-PEG5000]-induced arginine depletion is selectively cytotoxic to human glioblastoma cellsOula Khoury, Noura Ghazale, Everett Stone, et al.
Pageof 26

Showing results (141-150 of 259) with videos related to

Sort By:
Pageof 26
Cancer Research|September 1, 1982
Monoclonal antibodies to a human prostate antigenA E Frankel, R V Rouse, M C Wang, et al.
Breast Cancer Research and Treatment|July 13, 2007
1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes inhibit proliferation of estrogen receptor-negative breast cancer cells by activation of multiple pathwaysKathy Vanderlaag, Yunpeng Su, Arthur E Frankel, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1989
An immunotoxin for the treatment of T-acute lymphoblastic leukemic meningitis: studies in rhesus monkeysA A Hertler, D M Schlossman, M J Borowitz, et al.
International Journal of Immunopharmacology|December 1, 1996
Ricin toxin contains three lectin sites which contribute to its in vivo toxicityT Fu, C Burbage, E P Tagge, et al.
Current Pharmaceutical Design|October 14, 2003
Novel protein targeted therapy of metastatic melanomaArthur E Frankel, Han-Mo Koo, Stephen H Leppla, et al.
Anti-Cancer Agents in Medicinal Chemistry|October 26, 2011
TEM8 targeted cancer therapyArthur E Frankel, Carol Carter, Shu-Ru Kuo, et al.
Clinical Immunology (Orlando, Fla.)|July 24, 2001
Antibody response to DT-GM, a novel fusion toxin consisting of a truncated diphtheria toxin (DT) linked to human granulocyte-macrophage colony stimulating factor (GM), during a phase I trial of patients with relapsed or refractory acute myeloid leukemiaP D Hall, G Virella, T Willoughby, et al.
Cancer Treatment and Research|January 1, 1988
Treatment of leukemia patients with T101 ricin A chain immunotoxinsG Laurent, A E Frankel, A A Hertler, et al.
Carbohydrate Research|May 16, 1997
Lectin-deficient ricin toxin intoxicates cells bearing the D-mannose receptorA E Frankel, T Fu, C Burbage, et al.
Journal of Neuro-Oncology|January 9, 2015
Human recombinant arginase I (Co)-PEG5000 [HuArgI (Co)-PEG5000]-induced arginine depletion is selectively cytotoxic to human glioblastoma cellsOula Khoury, Noura Ghazale, Everett Stone, et al.
Pageof 26